Biology Reference
In-Depth Information
[65] Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, et al.
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in
patients with cancer. Blood 2005;105(8):3051-7.
[66] Rubnitz JE, Inaba H, Ribeiro RC, Pounds S, Rooney B, Bell T, et al. NKAML: a pilot study
to determine the safety and feasibility of haploidentical natural killer cell transplanta-
tion in childhood acute myeloid leukemia. J Clin Oncol 2010;28(6):955-9.
[67] Carpenter PA, Snyder DS, Flowers ME, Sanders JE, Gooley TA, Martin PJ, et al. Prophy-
lactic administration of imatinib after hematopoietic cell transplantation for high-risk
Philadelphia chromosome-positive leukemia. Blood 2007;109(7):2791-3.
[68] de Lima M, Giralt S, Thall PF, de Padua Silva L, Jones RB, Komanduri K, et al. Main-
tenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell
transplantation for recurrent acute myelogenous leukemia or myelodysplastic syn-
drome: a dose and schedule finding study. Cancer 2010;116(23):5420-31.
[69] Mastaglio S, Stanghellini MT, Bordignon C, Bondanza A, Ciceri F, Bonini C. Progress and
prospects: graft-versus-host disease. Gene Ther 2010;17(11):1309-17.
[70] Di Stasi A, Tey SK, Dotti G, Fujita Y, Kennedy-Nasser A, Martinez C, et al. Inducible apop-
tosis as a safety switch for adoptive cell therapy. N Engl J Med 2011;365(18):1673-83.
[71] Urba WJ, Longo DL. Redirecting T cells. N Engl J Med 2011;365(8):754-7.
[72] Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, et al. T cells with chimeric anti-
gen receptors have potent antitumor effects and can establish memory in patients with
advanced leukemia. Sci Transl Med 2011;3(95): ra7395.
[73] Hoyos V, Savoldo B, Quintarelli C, Mahendravada A, Zhang M, Vera J, et al. Engineering
CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their
anti-lymphoma/leukemia effects and safety. Leukemia 2010;24(6):1160-70.
[74] Heslop HE. Safer CARS. Mol Ther 2010 Apr;18(4):661-2.
508
